• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥克尼群岛和设得兰群岛的多发性硬化症。I:流行病学、临床因素及方法学

Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology.

作者信息

Poskanzer D C, Prenney L B, Sheridan J L, Kondy J Y

出版信息

J Epidemiol Community Health. 1980 Dec;34(4):229-39. doi: 10.1136/jech.34.4.229.

DOI:10.1136/jech.34.4.229
PMID:7241022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1052085/
Abstract

An epidemiological and clinical study of multiple sclerosis (MS) in the Orkney and Shetland Islands showed that the prevalence rate of the disease is the highest in the world (309 and 184/100 000, respectively). The clinical entity, MS, is similar to that found in other parts of the world, except that optic neuritis not followed by MS is rare. Analysis of death certificates indicated that MS has probably occurred at the same rate in these islands for nearly a century. Although the incidence of MS is high, the incidence rate has remained constant over time. A rapidly increasing prevalence of MS has occurred in Orkney, with a more modest increase in Shetland, over the past 20 years, which is largely due to an increase in survival. Demographic factors, case ascertainment, and emigration have contributed little to the increasing prevalence of MS in these islands.

摘要

一项针对奥克尼群岛和设得兰群岛多发性硬化症(MS)的流行病学和临床研究表明,该疾病的患病率是世界上最高的(分别为309/10万和184/10万)。MS这种临床病症与世界其他地区发现的类似,只是不继发于MS的视神经炎很少见。对死亡证明的分析表明,近一个世纪以来,这些岛屿上MS的发病率可能一直相同。尽管MS的发病率很高,但发病率随时间保持稳定。在过去20年里,奥克尼群岛MS的患病率迅速上升,设得兰群岛的上升幅度较小,这主要是由于生存率的提高。人口统计学因素、病例确诊和移民对这些岛屿上MS患病率的上升贡献不大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45f/1052085/02e595c7685f/jepicomh00261-0007-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45f/1052085/18d6d2156cb0/jepicomh00261-0006-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45f/1052085/02e595c7685f/jepicomh00261-0007-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45f/1052085/18d6d2156cb0/jepicomh00261-0006-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45f/1052085/02e595c7685f/jepicomh00261-0007-a.jpg

相似文献

1
Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology.奥克尼群岛和设得兰群岛的多发性硬化症。I:流行病学、临床因素及方法学
J Epidemiol Community Health. 1980 Dec;34(4):229-39. doi: 10.1136/jech.34.4.229.
2
Multiple sclerosis in the Orkney and Shetland Islands. VI: The effects of migration and social structure.奥克尼群岛和设得兰群岛的多发性硬化症。VI:移民与社会结构的影响。
J Epidemiol Community Health. 1980 Dec;34(4):271-6. doi: 10.1136/jech.34.4.271.
3
The prevalence of multiple sclerosis in the Outer Hebrides compared with north-east Scotland and the Orkney and Shetland Islands.与苏格兰东北部以及奥克尼群岛和设得兰群岛相比,外赫布里底群岛多发性硬化症的患病率。
J Epidemiol Community Health. 1981 Jun;35(2):110-3. doi: 10.1136/jech.35.2.110.
4
Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands.奥克尼群岛和设得兰群岛多发性硬化症的流行病学研究。
Neurology. 1976 Jun;26(6 PT 2):14-7. doi: 10.1212/wnl.26.6_part_2.14.
5
A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city.奥克尼群岛、设得兰群岛和阿伯丁市多发性硬化症的新患病率研究。
J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):719-24. doi: 10.1136/jnnp-2011-301546. Epub 2012 May 10.
6
The risk of multiple sclerosis on the Orkney islands. A review of the search for distinctively Orcadian risks, with a hypothesis for further investigations.奥克尼群岛多发性硬化症的发病风险。奥克尼群岛特有的发病风险因素研究综述,提出进一步调查的假设。
Mult Scler Relat Disord. 2024 Feb;82:105386. doi: 10.1016/j.msard.2023.105386. Epub 2023 Dec 30.
7
Multiple sclerosis in the Orkney and Shetland Islands. IV: Viral antibody titres and viral infections.奥克尼群岛和设得兰群岛的多发性硬化症。IV:病毒抗体滴度与病毒感染
J Epidemiol Community Health. 1980 Dec;34(4):258-64. doi: 10.1136/jech.34.4.258.
8
The Shetland-Orkney-Faroe Project.设得兰-奥克尼-法罗项目
Acta Neurol Scand. 1966;42(S19):6-8. doi: 10.1111/j.1600-0404.1966.tb01995.x.
9
The etiology of multiple sclerosis: temporal-spatial clustering indicating two environmental exposures before onset.多发性硬化症的病因:时空聚集表明发病前有两种环境暴露因素。
Neurology. 1981 Jun;31(6):708-13. doi: 10.1212/wnl.31.6.708.
10
Contribution of common risk variants to multiple sclerosis in Orkney and Shetland.奥克尼群岛和设得兰群岛多发性硬化症的常见风险变异贡献。
Eur J Hum Genet. 2021 Nov;29(11):1701-1709. doi: 10.1038/s41431-021-00914-w. Epub 2021 Jun 4.

引用本文的文献

1
FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis.未来 MS 队列特征:苏格兰多中心首发队列研究多发性硬化症复发缓解型。
BMJ Open. 2022 Jun 29;12(6):e058506. doi: 10.1136/bmjopen-2021-058506.
2
Genome-wide homozygosity and multiple sclerosis in Orkney and Shetland Islanders.全基因组纯合性与奥克尼群岛和设得兰群岛居民多发性硬化症。
Eur J Hum Genet. 2012 Feb;20(2):198-202. doi: 10.1038/ejhg.2011.170. Epub 2011 Sep 7.
3
The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria.

本文引用的文献

1
The course of multiple sclerosis as determined by autopsy proven cases.经尸检证实的多发性硬化症病程。
Res Publ Assoc Res Nerv Ment Dis. 1950;28:471-511.
2
Multiple sclerosis in a rural community.农村社区的多发性硬化症
Res Publ Assoc Res Nerv Ment Dis. 1950;28:25-7.
3
The frequency and geographic distribution of multiple sclerosis as indicated by mortality statistics and morbidity surveys in the United States and Canada.根据美国和加拿大的死亡率统计及发病率调查显示的多发性硬化症的发病频率和地理分布。
德文郡多发性硬化症的流行病学:新旧分类标准的比较
J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):56-60.
4
High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition.苏格兰东南部多发性硬化症的高发病率和患病率:遗传易感性证据。
J Neurol Neurosurg Psychiatry. 1998 Jun;64(6):730-5. doi: 10.1136/jnnp.64.6.730.
5
The prevalence of multiple sclerosis in the Leeds Health Authority.利兹卫生局辖区内多发性硬化症的患病率。
J Neurol Neurosurg Psychiatry. 1998 May;64(5):605-10. doi: 10.1136/jnnp.64.5.605.
6
Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register.剑桥郡南部的多发性硬化症:基于地区登记册的发病率和患病率
J Epidemiol Community Health. 1996 Jun;50(3):274-9. doi: 10.1136/jech.50.3.274.
7
Epidemiologic evidence for multiple sclerosis as an infection.多发性硬化症作为一种感染性疾病的流行病学证据。
Clin Microbiol Rev. 1993 Oct;6(4):382-427. doi: 10.1128/CMR.6.4.382.
8
A prevalence survey of multiple sclerosis in Sussex.苏塞克斯郡多发性硬化症患病率调查。
J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):27-30. doi: 10.1136/jnnp.58.1.27.
9
Multiple sclerosis in island populations: prevalence in the Bailiwicks of Guernsey and Jersey.岛屿人群中的多发性硬化症:根西岛和泽西岛辖区的患病率
J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):22-6. doi: 10.1136/jnnp.58.1.22.
10
Surveying multiple sclerosis in the United Kingdom.英国多发性硬化症调查
J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):2-6. doi: 10.1136/jnnp.58.1.2.
Am J Hyg. 1952 May;55(3):457-81. doi: 10.1093/oxfordjournals.aje.a119535.
4
Prevalence and incidence of multiple sclerosis in Boston, 1939-1948; preliminary report.1939 - 1948年波士顿多发性硬化症的患病率和发病率;初步报告。
AMA Arch Neurol Psychiatry. 1950 Nov;64(5):631-40. doi: 10.1001/archneurpsyc.1950.02310290027003.
5
MULTIPLE SCLEROSIS IN WINNIPEG, MANITOBA: METHODOLOGICAL CONSIDERATIONS OF EPIDEMIOLOGIC SURVEY. TEN YEAR FOLLOW-UP OF A COMMUNITY WIDE STUDY, AND POPULATION RE-SURVEY.加拿大马尼托巴省温尼伯市的多发性硬化症:流行病学调查的方法学考量。一项社区范围研究的十年随访及人口再调查
J Chronic Dis. 1964 May;17:415-38. doi: 10.1016/0021-9681(64)90102-x.
6
The prevalence of multiple sclerosis in Australia.澳大利亚多发性硬化症的患病率。
Brain. 1962 Mar;85:149-64. doi: 10.1093/brain/85.1.149.
7
Lethality, duration, and mortality of disseminated sclerosis in Denmark.丹麦播散性硬化症的致死率、病程及死亡率。
Acta Psychiatr Scand. 1961;36(4):553-64. doi: 10.1111/j.1600-0447.1961.tb01774.x.
8
Disseminated sclerosis; a survey of patients in the Kingston, Ontario, area.
Neurology. 1959 Apr;9(4):256-72. doi: 10.1212/wnl.9.4.256.
9
Observations on the prevalence of multiple sclerosis in Northern Scotland.苏格兰北部多发性硬化症患病率观察
Brain. 1956 Dec;79(4):635-54. doi: 10.1093/brain/79.4.635.
10
Multiple sclerosis, its onset and duration; a clinical study of 309 private patients.
Med Clin North Am. 1953 Mar;37(2):511-21. doi: 10.1016/s0025-7125(16)35027-1.